膠芽腫治療薬の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9100019）

◆英語タイトル：Global Glioblastoma Treatment Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9100019
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年10月（※2024年版があります。お問い合わせください）
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、膠芽腫治療薬の世界市場について調べ、まとめました。種類別セグメントは、VEGF / VEGFR阻害剤、アルキル化剤、その他の抗腫瘍薬等、用途別セグメントは、病院、がん研究機構、長期介護センター、診断センター等に区分しました。膠芽腫治療薬の世界市場概観、メーカー動向、メーカー別膠芽腫治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・膠芽腫治療薬の市場概観
・膠芽腫治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・膠芽腫治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・膠芽腫治療薬の世界市場規模
・膠芽腫治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・膠芽腫治療薬のアメリカ市場規模推移
・膠芽腫治療薬のカナダ市場規模推移
・膠芽腫治療薬のメキシコ市場規模推移
・膠芽腫治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・膠芽腫治療薬のドイツ市場規模推移
・膠芽腫治療薬のイギリス市場規模推移
・膠芽腫治療薬のロシア市場規模推移
・膠芽腫治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・膠芽腫治療薬の日本市場規模推移
・膠芽腫治療薬の中国市場規模推移
・膠芽腫治療薬の韓国市場規模推移
・膠芽腫治療薬のインド市場規模推移
・膠芽腫治療薬の東南アジア市場規模推移
・膠芽腫治療薬の南米市場分析（ブラジル、アルゼンチン等）
・膠芽腫治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・膠芽腫治療薬の種類別分析/販売量、売上、市場シェア（VEGF / VEGFR阻害剤、アルキル化剤、その他の抗腫瘍薬）
・膠芽腫治療薬の用途別分析/市場規模（病院、がん研究機構、長期介護センター、診断センター）
・膠芽腫治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・膠芽腫治療薬の販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Scope of the Report:
The worldwide market for Glioblastoma Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Glioblastoma Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sigma-Tau Pharmaceuticals
F. Hoffmann-La Roche AG
Bristol-Myers Squibb Company
Arbor Pharms LLC.
Emcure Pharmaceuticals Ltd.
Sandoz
Merck & Co.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
VEGF/VEGFR Inhibitor
Alkylating Agents
Miscellaneous Antineoplastic

Market Segment by Applications, can be divided into
Hospital
Cancer Research Organization
Long Term Care Center
Diagnostic Centers

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glioblastoma Treatment Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glioblastoma Treatment Drugs, with price, sales, revenue and global market share of Glioblastoma Treatment Drugs in 2017 and 2018.
Chapter 3, the Glioblastoma Treatment Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glioblastoma Treatment Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Glioblastoma Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Glioblastoma Treatment Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Glioblastoma Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 VEGF/VEGFR Inhibitor
1.2.2 Alkylating Agents
1.2.3 Miscellaneous Antineoplastic
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Cancer Research Organization
1.3.3 Long Term Care Center
1.3.4 Diagnostic Centers
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sigma-Tau Pharmaceuticals
2.1.1 Business Overview
2.1.2 Glioblastoma Treatment Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sigma-Tau Pharmaceuticals Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 F. Hoffmann-La Roche AG
2.2.1 Business Overview
2.2.2 Glioblastoma Treatment Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche AG Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bristol-Myers Squibb Company
2.3.1 Business Overview
2.3.2 Glioblastoma Treatment Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Company Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Arbor Pharms LLC.
2.4.1 Business Overview
2.4.2 Glioblastoma Treatment Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Arbor Pharms LLC. Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Emcure Pharmaceuticals Ltd.
2.5.1 Business Overview
2.5.2 Glioblastoma Treatment Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Emcure Pharmaceuticals Ltd. Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sandoz
2.6.1 Business Overview
2.6.2 Glioblastoma Treatment Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sandoz Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck & Co.
2.7.1 Business Overview
2.7.2 Glioblastoma Treatment Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck & Co. Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Glioblastoma Treatment Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Glioblastoma Treatment Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Glioblastoma Treatment Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Glioblastoma Treatment Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Glioblastoma Treatment Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Glioblastoma Treatment Drugs Market Analysis by Regions
4.1 Global Glioblastoma Treatment Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Glioblastoma Treatment Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Glioblastoma Treatment Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
4.5 South America Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
5 North America Glioblastoma Treatment Drugs by Country
5.1 North America Glioblastoma Treatment Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Glioblastoma Treatment Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Glioblastoma Treatment Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
6 Europe Glioblastoma Treatment Drugs by Country
6.1 Europe Glioblastoma Treatment Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Glioblastoma Treatment Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Glioblastoma Treatment Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
6.3 UK Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
6.4 France Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Glioblastoma Treatment Drugs by Country
7.1 Asia-Pacific Glioblastoma Treatment Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Glioblastoma Treatment Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Glioblastoma Treatment Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
7.5 India Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
8 South America Glioblastoma Treatment Drugs by Country
8.1 South America Glioblastoma Treatment Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Glioblastoma Treatment Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Glioblastoma Treatment Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Glioblastoma Treatment Drugs by Countries
9.1 Middle East and Africa Glioblastoma Treatment Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Glioblastoma Treatment Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Glioblastoma Treatment Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
10 Global Glioblastoma Treatment Drugs Market Segment by Type
10.1 Global Glioblastoma Treatment Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Glioblastoma Treatment Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Glioblastoma Treatment Drugs Revenue and Market Share by Type (2014-2019)
10.2 VEGF/VEGFR Inhibitor Sales Growth and Price
10.2.1 Global VEGF/VEGFR Inhibitor Sales Growth (2014-2019)
10.2.2 Global VEGF/VEGFR Inhibitor Price (2014-2019)
10.3 Alkylating Agents Sales Growth and Price
10.3.1 Global Alkylating Agents Sales Growth (2014-2019)
10.3.2 Global Alkylating Agents Price (2014-2019)
10.4 Miscellaneous Antineoplastic Sales Growth and Price
10.4.1 Global Miscellaneous Antineoplastic Sales Growth (2014-2019)
10.4.2 Global Miscellaneous Antineoplastic Price (2014-2019)
11 Global Glioblastoma Treatment Drugs Market Segment by Application
11.1 Global Glioblastoma Treatment Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Cancer Research Organization Sales Growth (2014-2019)
11.4 Long Term Care Center Sales Growth (2014-2019)
11.5 Diagnostic Centers Sales Growth (2014-2019)
12 Glioblastoma Treatment Drugs Market Forecast (2019-2024)
12.1 Global Glioblastoma Treatment Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Glioblastoma Treatment Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Glioblastoma Treatment Drugs Market Forecast (2019-2024)
12.2.2 Europe Glioblastoma Treatment Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Glioblastoma Treatment Drugs Market Forecast (2019-2024)
12.2.4 South America Glioblastoma Treatment Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Glioblastoma Treatment Drugs Market Forecast (2019-2024)
12.3 Glioblastoma Treatment Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Glioblastoma Treatment Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Glioblastoma Treatment Drugs Market Share Forecast by Type (2019-2024)
12.4 Glioblastoma Treatment Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Glioblastoma Treatment Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Glioblastoma Treatment Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Glioblastoma Treatment Drugs Picture
Table Product Specifications of Glioblastoma Treatment Drugs
Figure Global Sales Market Share of Glioblastoma Treatment Drugs by Types in 2018
Table Glioblastoma Treatment Drugs Types for Major Manufacturers
Figure VEGF/VEGFR Inhibitor Picture
Figure Alkylating Agents Picture
Figure Miscellaneous Antineoplastic Picture
Figure Glioblastoma Treatment Drugs Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Cancer Research Organization Picture
Figure Long Term Care Center Picture
Figure Diagnostic Centers Picture
Figure United States Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Glioblastoma Treatment Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Sigma-Tau Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sigma-Tau Pharmaceuticals Glioblastoma Treatment Drugs Type and Applications
Table Sigma-Tau Pharmaceuticals Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche AG Glioblastoma Treatment Drugs Type and Applications
Table F. Hoffmann-La Roche AG Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Glioblastoma Treatment Drugs Type and Applications
Table Bristol-Myers Squibb Company Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Arbor Pharms LLC. Basic Information, Manufacturing Base and Competitors
Table Arbor Pharms LLC. Glioblastoma Treatment Drugs Type and Applications
Table Arbor Pharms LLC. Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Emcure Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table Emcure Pharmaceuticals Ltd. Glioblastoma Treatment Drugs Type and Applications
Table Emcure Pharmaceuticals Ltd. Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sandoz Basic Information, Manufacturing Base and Competitors
Table Sandoz Glioblastoma Treatment Drugs Type and Applications
Table Sandoz Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Glioblastoma Treatment Drugs Type and Applications
Table Merck & Co. Glioblastoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Glioblastoma Treatment Drugs Sales by Manufacturer (2017-2018)
Figure Global Glioblastoma Treatment Drugs Sales Market Share by Manufacturer in 2017
Figure Global Glioblastoma Treatment Drugs Sales Market Share by Manufacturer in 2018
Table Global Glioblastoma Treatment Drugs Revenue by Manufacturer (2017-2018)
Figure Global Glioblastoma Treatment Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Glioblastoma Treatment Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Glioblastoma Treatment Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Glioblastoma Treatment Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Global Glioblastoma Treatment Drugs Revenue and Growth Rate (2014-2019)
Table Global Glioblastoma Treatment Drugs Sales by Regions (2014-2019)
Table Global Glioblastoma Treatment Drugs Sales Market Share by Regions (2014-2019)
Table Global Glioblastoma Treatment Drugs Revenue by Regions (2014-2019)
Figure Global Glioblastoma Treatment Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Glioblastoma Treatment Drugs Revenue Market Share by Regions in 2018
Figure North America Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure South America Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure North America Glioblastoma Treatment Drugs Revenue and Growth Rate (2014-2019)
Table North America Glioblastoma Treatment Drugs Sales by Countries (2014-2019)
Table North America Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure North America Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure North America Glioblastoma Treatment Drugs Sales Market Share by Countries in 2018
Table North America Glioblastoma Treatment Drugs Revenue by Countries (2014-2019)
Table North America Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Glioblastoma Treatment Drugs Revenue Market Share by Countries in 2018
Figure United States Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Canada Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Revenue and Growth Rate (2014-2019)
Table Europe Glioblastoma Treatment Drugs Sales by Countries (2014-2019)
Table Europe Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Table Europe Glioblastoma Treatment Drugs Revenue by Countries (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Revenue Market Share by Countries in 2018
Figure Germany Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure UK Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure France Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Russia Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Italy Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Glioblastoma Treatment Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Glioblastoma Treatment Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Glioblastoma Treatment Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Glioblastoma Treatment Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Glioblastoma Treatment Drugs Revenue Market Share by Countries 2018
Figure China Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Japan Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Korea Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure India Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure South America Glioblastoma Treatment Drugs Revenue and Growth Rate (2014-2019)
Table South America Glioblastoma Treatment Drugs Sales by Countries (2014-2019)
Table South America Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure South America Glioblastoma Treatment Drugs Sales Market Share by Countries in 2018
Table South America Glioblastoma Treatment Drugs Revenue by Countries (2014-2019)
Table South America Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Glioblastoma Treatment Drugs Revenue Market Share by Countries in 2018
Figure Brazil Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Glioblastoma Treatment Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Glioblastoma Treatment Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure UAE Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Glioblastoma Treatment Drugs Sales and Growth Rate (2014-2019)
Table Global Glioblastoma Treatment Drugs Sales by Type (2014-2019)
Table Global Glioblastoma Treatment Drugs Sales Share by Type (2014-2019)
Table Global Glioblastoma Treatment Drugs Revenue by Type (2014-2019)
Table Global Glioblastoma Treatment Drugs Revenue Share by Type (2014-2019)
Figure Global VEGF/VEGFR Inhibitor Sales Growth (2014-2019)
Figure Global VEGF/VEGFR Inhibitor Price (2014-2019)
Figure Global Alkylating Agents Sales Growth (2014-2019)
Figure Global Alkylating Agents Price (2014-2019)
Figure Global Miscellaneous Antineoplastic Sales Growth (2014-2019)
Figure Global Miscellaneous Antineoplastic Price (2014-2019)
Table Global Glioblastoma Treatment Drugs Sales by Application (2014-2019)
Table Global Glioblastoma Treatment Drugs Sales Share by Application (2014-2019)
Figure Global Hospital Sales Growth (2014-2019)
Figure Global Cancer Research Organization Sales Growth (2014-2019)
Figure Global Long Term Care Center Sales Growth (2014-2019)
Figure Global Diagnostic Centers Sales Growth (2014-2019)
Figure Global Glioblastoma Treatment Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Glioblastoma Treatment Drugs Sales Forecast by Regions (2019-2024)
Table Global Glioblastoma Treatment Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Glioblastoma Treatment Drugs Market Forecast (2019-2024)
Figure Europe Sales Glioblastoma Treatment Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Glioblastoma Treatment Drugs Market Forecast (2019-2024)
Figure South America Sales Glioblastoma Treatment Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Glioblastoma Treatment Drugs Market Forecast (2019-2024)
Table Global Glioblastoma Treatment Drugs Sales Forecast by Type (2019-2024)
Table Global Glioblastoma Treatment Drugs Market Share Forecast by Type (2019-2024)
Table Global Glioblastoma Treatment Drugs Sales Forecast by Application (2019-2024)
Table Global Glioblastoma Treatment Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

【掲載企業】

Sigma-Tau Pharmaceuticals、 F. Hoffmann-La Roche AG、 Bristol-Myers Squibb Company、 Arbor Pharms LLC.、 Emcure Pharmaceuticals Ltd.、 Sandoz、 Merck & Co.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 膠芽腫治療薬の世界市場2019(Global Glioblastoma Treatment Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp